Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000318306-16-000045
Filing Date
2016-02-16
Accepted
2016-02-16 17:36:47
Documents
1
Period of Report
2016-02-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6169
  Complete submission text file 0000318306-16-000045.txt   8081
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019
Business Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019 212-554-4158
Jeffrey B Davis (Reporting) CIK: 0001349083 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 161430618